Futura Medical (FRA:GYX) Debt-to-Asset : 0.00 (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Futura Medical Debt-to-Asset?

Futura Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.00 Mil. Futura Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.00 Mil. Futura Medical's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was €11.19 Mil. Futura Medical's debt to asset for the quarter that ended in Jun. 2024 was 0.00.

Futura Medical Debt-to-Asset Historical Data

The historical data trend for Futura Medical's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Debt-to-Asset Chart

Futura Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

Futura Medical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Futura Medical's Debt-to-Asset

For the Biotechnology subindustry, Futura Medical's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Futura Medical's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Futura Medical's Debt-to-Asset falls into.

Futura Medical Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Futura Medical's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	13.716
	=	0.00

Futura Medical's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	11.188
	=	0.00

Futura Medical (FRA:GYX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Futura Medical Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Futura Medical's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Futura Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (FRA:GYX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

FAMDF:USA FUM:UK

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.

Futura Medical Headlines

No Headlines